SecSonar.com

Eli Lilly and Company (LLY)

Eli Lilly and Company at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Eli Lilly and Company (LLY) is a Drug Manufacturers - General company based in US with a market capitalization of $1T. Revenue grew 44.7% year-over-year and the company generated $9B in free cash flow. This page tracks LLY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 47K employees · IPO Jun 1, 1972

Valuation

Valuation & price

$1002.00 · as of May 13, 2026 · -17.1% vs 52w high

43.6

P/E ratio

Latest-FY diluted EPS

38.86

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.2K$917$626Jul 25Dec 25Jun 26Jul 7, 25$772.87Jul 9, 25$786.92Jul 11, 25$793.01Jul 15, 25$771.75Jul 17, 25$761.50Jul 21, 25$762.18Jul 23, 25$798.89Jul 25, 25$812.69Jul 29, 25$762.95Jul 31, 25$740.07Aug 4, 25$769.00Aug 6, 25$746.37Aug 8, 25$625.65Aug 12, 25$639.43Aug 14, 25$684.43Aug 18, 25$698.05Aug 20, 25$705.44Aug 22, 25$711.68Aug 26, 25$736.03Aug 28, 25$731.96Sep 3, 25$737.83Sep 5, 25$727.21Sep 9, 25$750.61Sep 11, 25$756.28Sep 15, 25$748.19Sep 17, 25$760.13Sep 19, 25$751.99Sep 23, 25$746.98Sep 25, 25$714.59Sep 29, 25$726.51Oct 1, 25$825.42Oct 3, 25$839.87Oct 7, 25$843.63Oct 9, 25$855.35Oct 13, 25$819.40Oct 15, 25$826.57Oct 17, 25$802.83Oct 21, 25$799.57Oct 23, 25$821.04Oct 27, 25$826.41Oct 30, 25$844.50Nov 3, 25$896.53Nov 5, 25$925.81Nov 7, 25$924.37Nov 11, 25$988.62Nov 13, 25$1022.87Nov 17, 25$1021.70Nov 19, 25$1049.60Nov 21, 25$1059.70Nov 25, 25$1109.94Nov 28, 25$1075.47Dec 2, 25$1046.12Dec 4, 25$1014.49Dec 8, 25$997.59Dec 10, 25$993.64Dec 12, 25$1027.51Dec 16, 25$1054.29Dec 18, 25$1056.88Dec 22, 25$1076.48Dec 24, 25$1076.98Dec 29, 25$1079.45Jan 2, 26$1080.36Jan 6, 26$1064.04Jan 8, 26$1085.19Jan 12, 26$1081.00Jan 14, 26$1073.29Jan 16, 26$1038.40Jan 21, 26$1078.52Jan 23, 26$1064.29Jan 27, 26$1039.51Jan 29, 26$1024.14Feb 2, 26$1044.13Feb 4, 26$1107.12Feb 6, 26$1058.18Feb 10, 26$1024.58Feb 12, 26$1038.27Feb 17, 26$1036.05Feb 19, 26$1023.22Feb 23, 26$1058.56Feb 25, 26$1028.83Mar 2, 26$1017.97Mar 4, 26$1003.57Mar 6, 26$990.33Mar 10, 26$1001.35Mar 12, 26$977.25Mar 16, 26$989.12Mar 18, 26$918.05Mar 20, 26$906.70Mar 24, 26$903.02Mar 26, 26$897.00Mar 30, 26$886.63Apr 1, 26$954.52Apr 6, 26$927.06Apr 8, 26$953.30Apr 10, 26$939.47Apr 14, 26$922.50Apr 16, 26$903.99Apr 20, 26$919.90Apr 22, 26$921.48Apr 24, 26$883.96Apr 28, 26$874.00May 1, 26$963.33May 5, 26$988.87May 7, 26$974.96May 11, 26$966.99May 13, 26$1015.75May 15, 26$1004.92May 19, 26$1021.41May 21, 26$1041.65May 26, 26$1064.74May 28, 26$1126.80Jun 1, 26$1082.20Jun 3, 26$1078.78Jun 5, 26$1131.42Jun 9, 26$1144.68Jun 11, 26$1160.95Jun 15, 26$1129.35Jun 17, 26$1112.00Jun 22, 26$1102.08Jun 26, 26$1208.12
$625.6552-week range$1208.12
Loading valuation history…

Fundamentals

Key fundamentals

$1T

Market cap

44.7%

Revenue growth (YoY)

83.8%

Gross margin

$9B

Free cash flow (USD)

$35.2B

Net debt

-0.3%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$21.2BFY 2017$20.0BFY 2018$21.5BFY 2019$22.3BFY 2020$24.5BFY 2021$28.3BFY 2022$28.5BFY 2023$34.1BFY 2024$45.0BFY 2025$65.2B
$21.2B$65.2B

Free cash flow by year

2016 → 2025

FY 2016$3.8BFY 2017$3.5BFY 2018$2.5BFY 2019$3.5BFY 2020$4.5BFY 2021$5.4BFY 2022$4.6BFY 2023$-3.2BFY 2024$414.3MFY 2025$9.0B
$3.8B$9B

Gross margin by year

2021 → 2025

FY 202174.2%FY 202276.8%FY 202379.3%FY 202481.3%FY 202583.8%
74.2%83.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $2.9M · 10b5-1 PlanYuffa Ilya · EVP&Pres, LLY USA&Global Capab · $2.9MJun 11, 2026Filing
  • 8-K eventDebt OfferingMay 20, 2026Filing
  • Insider sellInsider Sell $15.8MLILLY ENDOWMENT INC · $15.8MMay 7, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 7, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is Eli Lilly and Company's market cap?

Eli Lilly and Company (LLY) has a market capitalization of $1T.

What is LLY's P/E ratio?

LLY trades at a price-to-earnings ratio of 43.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is LLY's price-to-book (P/B) ratio?

LLY trades at 38.86 times book value per share.

Are insiders buying LLY stock?

SEC Form 4 filings show no open-market insider buys at Eli Lilly and Company in the last 90 days (2 sells).

Same arena

Related companies in Drug Manufacturers - General

JNJ

Johnson & Johnson

$542.9B

ABBV

AbbVie Inc.

$382B

MRK

Merck & Co., Inc.

$293.4B

AZN

AstraZeneca PLC

$288.5B

NVS

Novartis AG

$287.1B

AMGN

Amgen Inc.

$180.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.